Dr. Acharya is a medical oncologist treating patients with leukemia, lymphoma, myelodysplastic syndrome and other blood disorders. His clinical expertise is in CAR T-cell therapy.
I believe that providing excellent patient care extends beyond just choosing the right chemotherapy regimen or treatment modality for a patient. I especially subscribe to the words of Dr. Francis Peabody, late 19th century physician and humanitarian, who once said "One of the essential qualities of the clinician is interest in humanity, for the secret of the care of the patient is in caring for the patient."
CAR T-cell therapy
- Assistant Professor, Division of Medical Oncology, University of Washington School of Medicine
- Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center
- DO: Ohio University
- Internship: University of South Florida
- Residency: Internal Medicine, The Ohio State University Wexner Medical Center
- Fellowship: Hematology-Oncology, University of Arizona Cancer Center
- Ohio State University Resident Educator Award, 2011, 2012
- Ohio State University Department of Internal Medicine Humanism Award, 2011,2012
- Arnold P. Gold Excellence In Teaching Award, 2012
- Alpha Omega Alpha Medical Honor Society
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
- Hematology, American Board of Internal Medicine
When Utkarsh (Utty) Acharya was an undergraduate student, he considered pursuing various study options, including a career in law, bench research and medicine. His biggest criteria in choosing his career path was to acquire a skill set that would allow him to help those less fortunate while affording him to practice his profession without geographic limitations. "I naturally opted to pursue a career in medicine for it allows me the privilege of helping others beyond just their medical needs, while not limiting me to any particular geography," he says.
One of Dr. Acharya's first patients on the wards during his third year as a medical student was an elderly woman with newly diagnosed acute myeloid leukemia. Despite receiving news of the cancer diagnosis, Dr. Acharya recalls that she demonstrated considerable grace and resiliency as she went through several rounds of chemotherapy prior to ultimately achieving remission. "While I find many aspects of medicine rewarding, I am especially thankful for the tutelage of my courageous cancer patients that entrust me with their care during one of the most vulnerable phases in their lives," he says.
Dr. Acharya notes that there have been considerable advances in the field of oncology over the past several decades but that there is much room for improvement. "With the emerging role of immunotherapy, it is my hope that cancer control will be more durable and the therapy more tolerable than current systemic treatment modalities afford," he says. Dr. Acharya is currently involved in immunotherapy clinical research.
Outside of work, Dr. Acharya enjoys writing, hiking, running, learning new languages, traveling, medical volunteer work, nature and staying dry (though he does realize this often times is difficult living in Seattle).